Renal Denervation: A Novel Therapy at the Crossroads of Imaging, Intervention, and Innovation

Area of Science:

• Cardiovascular Medicine
• Nephrology
• Medical Devices

Background:

• Hypertension (HTN) affects millions, causing significant cardiovascular, renal, and neurovascular morbidity and mortality.
• Despite available pharmacologic treatments, many patients do not achieve target blood pressure (BP) control.
• There is a need for alternative or adjunctive therapies for managing resistant hypertension.

Purpose of the Study:

• To explore renal denervation as a device-based approach to modulate the autonomic nervous system for hypertension treatment.
• To review the evolution of renal denervation from promising early trials to concerns raised by larger studies.
• To highlight ongoing research in image-guided sympathetic nervous system manipulation for HTN.

Main Methods:

• Review of early and larger clinical trials investigating renal denervation devices.
• Analysis of the effectiveness and safety concerns associated with renal denervation procedures.
• Examination of the role of autonomic nervous system modulation in hypertension management.

Main Results:

• Initial renal denervation trials demonstrated favorable outcomes with minimal side effects.
• Subsequent larger trials have raised concerns regarding the short- and long-term effectiveness of renal denervation.
• Focus has shifted back to procedural techniques and operational details in response to trial results.

Conclusions:

• Renal denervation emerged as a novel device-based strategy for hypertension, targeting sympathetic nervous system activity.
• Despite initial enthusiasm, concerns about efficacy have tempered widespread adoption.
• Image-guided sympathetic nervous system modulation remains an active area of research for hypertension treatment.